MeSH tree: E04.100.376.485
Patients with moderate aortic stenosis, a narrowing of the heart's aortic valve, may benefit from undergoing transcatheter aortic valve replacement (TAVR) before the disease becomes severe, according to findings from a clinical ...
4 hours ago
0
0
New research published in JSCAI and presented at New York Valves 2026 reports favorable one-year outcomes in patients with symptomatic severe aortic regurgitation following treatment with the investigational J-Valve Transfemoral ...
Jun 25, 2026
0
3
Growing demand for a minimally invasive aortic valve replacement by adults under 65 with aortic stenosis may put many at greater risk for potentially more complicated heart surgeries later, according to a University of Rochester ...
May 27, 2026
0
6
New research found that public interest in Transcatheter Aortic Valve Replacement (TAVR) increased substantially over the last decade, with Google search volume rising by 340% from 2015 to 2025, while searches for SAVR (Surgical ...
Apr 23, 2026
0
4
Findings from the AltaValve Early Feasibility Study suggest that patients with a leaky mitral valve have sustained clinical benefits one year following atrial fixation Transcatheter Mitral Valve Replacement (TMVR). Researchers ...
Apr 23, 2026
0
6
Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable outcomes regardless of whether they underwent percutaneous coronary intervention (PCI) before TAVR, according ...
Mar 31, 2026
0
4
In the first head-to-head comparison of two devices intended to protect against stroke in patients undergoing transcatheter aortic valve replacement (TAVR), the investigational Emboliner device performed comparably to the ...
Mar 30, 2026
0
3
An analysis of approximately 1,604 studies from over three decades proves that delirium is a clinically highly relevant but scientifically often neglected complication in cardiology, and prevention can reduce the incidence ...
Feb 20, 2026
0
12
At the 2026 Society of Thoracic Surgeons (STS) Annual Meeting, investigators presented a late-breaking study focused on surgical aortic valve replacement (SAVR) following prior transcatheter aortic valve replacement (TAVR), ...
Jan 29, 2026
0
7
The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe aortic stenosis without symptoms. The approval ...
May 6, 2025
0
16
